<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Algotar</surname>
   <given-names>AM</given-names>
  </name>
  <name>
   <surname>Stratton</surname>
   <given-names>MS</given-names>
  </name>
  <name>
   <surname>Ahmann</surname>
   <given-names>FR</given-names>
  </name>
  <name>
   <surname>Ranger-Moore</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Nagle</surname>
   <given-names>RB</given-names>
  </name>
  <name>
   <surname>Thompson</surname>
   <given-names>PA</given-names>
  </name>
  <name>
   <surname>Slate</surname>
   <given-names>E</given-names>
  </name>
  <name>
   <surname>Hsu</surname>
   <given-names>CH</given-names>
  </name>
  <name>
   <surname>Dalkin</surname>
   <given-names>BL</given-names>
  </name>
  <name>
   <surname>Sindhwani</surname>
   <given-names>P</given-names>
  </name>
  <name>
   <surname>Holmes</surname>
   <given-names>MA</given-names>
  </name>
  <name>
   <surname>Tuckey</surname>
   <given-names>JA</given-names>
  </name>
  <name>
   <surname>Graham</surname>
   <given-names>DL</given-names>
  </name>
  <name>
   <surname>Parnes</surname>
   <given-names>HL</given-names>
  </name>
  <name>
   <surname>Clark</surname>
   <given-names>LC</given-names>
  </name>
  <name>
   <surname>Stratton</surname>
   <given-names>SP</given-names>
  </name>
  <article-title>Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer</article-title>
  <source>Prostate</source>
  <year>2013</year>
  <volume>73</volume>
  <fpage>328</fpage>
  <lpage>335</lpage>
  <pub-id pub-id-type="doi">10.1002/pros.22573</pub-id>
  <?supplied-pmid 22887343?>
  <pub-id pub-id-type="pmid">22887343</pub-id>
 </mixed-citation>
</ref>
